Free Trial

Lazard Asset Management LLC Has $1.24 Million Stock Holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Sabra Health Care REIT logo with Finance background

Lazard Asset Management LLC grew its stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 44.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 71,847 shares of the real estate investment trust's stock after acquiring an additional 22,019 shares during the quarter. Lazard Asset Management LLC's holdings in Sabra Health Care REIT were worth $1,244,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. VSM Wealth Advisory LLC bought a new stake in shares of Sabra Health Care REIT in the 4th quarter valued at about $26,000. Assetmark Inc. increased its stake in shares of Sabra Health Care REIT by 33.4% in the 4th quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust's stock valued at $45,000 after acquiring an additional 656 shares during the last quarter. Jones Financial Companies Lllp increased its stake in shares of Sabra Health Care REIT by 208.3% in the 4th quarter. Jones Financial Companies Lllp now owns 6,222 shares of the real estate investment trust's stock valued at $108,000 after acquiring an additional 4,204 shares during the last quarter. FIL Ltd increased its stake in Sabra Health Care REIT by 40.4% during the 4th quarter. FIL Ltd now owns 6,512 shares of the real estate investment trust's stock worth $113,000 after purchasing an additional 1,873 shares in the last quarter. Finally, Autumn Glory Partners LLC bought a new stake in Sabra Health Care REIT during the 4th quarter worth approximately $173,000. 99.40% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Truist Financial increased their target price on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "hold" rating in a research note on Tuesday, March 18th. Scotiabank increased their target price on Sabra Health Care REIT from $18.00 to $19.00 and gave the stock a "sector perform" rating in a research note on Monday, May 12th. Three research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $19.50.

Check Out Our Latest Analysis on Sabra Health Care REIT

Sabra Health Care REIT Stock Up 2.0%

NASDAQ:SBRA traded up $0.35 during trading hours on Friday, reaching $17.44. 2,710,400 shares of the stock were exchanged, compared to its average volume of 2,205,437. Sabra Health Care REIT, Inc. has a twelve month low of $13.87 and a twelve month high of $20.03. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16. The firm has a 50 day moving average of $17.52 and a 200 day moving average of $17.37. The stock has a market cap of $4.15 billion, a PE ratio of 32.91, a PEG ratio of 1.97 and a beta of 0.88.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share for the quarter, topping analysts' consensus estimates of $0.36 by $0.01. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. The firm had revenue of $183.54 million during the quarter, compared to the consensus estimate of $180.23 million. During the same quarter in the prior year, the firm posted $0.35 EPS. The business's revenue was up 10.1% on a year-over-year basis. On average, equities analysts expect that Sabra Health Care REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Health Care REIT Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 30th. Shareholders of record on Friday, May 16th will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 6.88%. The ex-dividend date is Friday, May 16th. Sabra Health Care REIT's dividend payout ratio (DPR) is currently 203.39%.

Insiders Place Their Bets

In other news, Director Michael J. Foster sold 11,000 shares of the stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total value of $200,420.00. Following the completion of the sale, the director now owns 64,725 shares of the company's stock, valued at approximately $1,179,289.50. This represents a 14.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 1.20% of the company's stock.

About Sabra Health Care REIT

(Free Report)

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Further Reading

Institutional Ownership by Quarter for Sabra Health Care REIT (NASDAQ:SBRA)

Should You Invest $1,000 in Sabra Health Care REIT Right Now?

Before you consider Sabra Health Care REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.

While Sabra Health Care REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Tech Stocks Insiders Are Buying: Speculative Plays for June
3 Defense Stocks Set to Crush the S&P This Summer
Analysts Are Watching These 4 Penny Stocks—You Should Too

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines